- Joined
- Jul 24, 2008
- Messages
- 33,627
- Points
- 0
<TABLE border=0 cellSpacing=0 cellPadding=0 width=452><TBODY><TR><TD vAlign=top width=452 colSpan=2>Published April 13, 2010
</TD></TR><TR><TD vAlign=top width=452 colSpan=2>China Animal Healthcare eyes HK dual listing
By LYNETTE KHOO
CHINA Animal Healthcare is singing the tune of dual listings, echoing the trend of S-chips that are seeking higher valuations elsewhere.
The company said yesterday that it plans to seek a dual primary listing on the Hong Kong Stock Exchange, together with a public offering of new shares.
'The directors are of the view that it is desirable and beneficial for the company to have dual primary listing status in both Singapore and Hong Kong so that the company can tap readily into two of Asia's most dynamic equity markets when the opportunity arises,' the group said in a statement.
'Furthermore, the Hong Kong dual listing will widen the investor base of the company so that the company may benefit from its exposure to a bigger range of private and institutional investors, and is expected to increase share trading liquidity.'
This dual listing is also in line with its focus on its business operations in China and is 'expected to further enhance the reputation of the company in the greater China region', the group added.
Similar reasons have been cited by other S-chips in the recent dual-listing fever.
Unlike China XLX, which dual-listed in Hong Kong by way of introduction (transferring shares from Singapore to Hong Kong) and saw its Hong Kong shares tank since the debut, Midas and Epure are planning to offer new shares to Hong Kong investors.
Despite a sterling debut, China XLX's Hong Kong-listed shares have since fallen to HK$3.39 (S$0.608) - below the Singapore shares closing of S$0.610 yesterday. Z-Obee, on the other hand, issued new shares in Hong Kong that have surged from their offer price of HK$1.80 to HK$3.21 at yesterday's closing.
Nevertheless, these frontrunners of the dual-listing trend here - China XLX and Z-Obee - have seen their share prices in Singapore improve by 19.6 per cent and 43.6 per cent respectively since their dual listings.
Hengxin Technology and Swing Media have also expressed their intent for dual listings, while Time Watch Investments is said to be exploring this option. Oceanus Group, meanwhile, has chosen the less travelled route of issuing Taiwan Depository Receipts.
</TD></TR></TBODY></TABLE>
</TD></TR><TR><TD vAlign=top width=452 colSpan=2>China Animal Healthcare eyes HK dual listing
By LYNETTE KHOO
CHINA Animal Healthcare is singing the tune of dual listings, echoing the trend of S-chips that are seeking higher valuations elsewhere.
The company said yesterday that it plans to seek a dual primary listing on the Hong Kong Stock Exchange, together with a public offering of new shares.
'The directors are of the view that it is desirable and beneficial for the company to have dual primary listing status in both Singapore and Hong Kong so that the company can tap readily into two of Asia's most dynamic equity markets when the opportunity arises,' the group said in a statement.
'Furthermore, the Hong Kong dual listing will widen the investor base of the company so that the company may benefit from its exposure to a bigger range of private and institutional investors, and is expected to increase share trading liquidity.'
This dual listing is also in line with its focus on its business operations in China and is 'expected to further enhance the reputation of the company in the greater China region', the group added.
Similar reasons have been cited by other S-chips in the recent dual-listing fever.
Unlike China XLX, which dual-listed in Hong Kong by way of introduction (transferring shares from Singapore to Hong Kong) and saw its Hong Kong shares tank since the debut, Midas and Epure are planning to offer new shares to Hong Kong investors.
Despite a sterling debut, China XLX's Hong Kong-listed shares have since fallen to HK$3.39 (S$0.608) - below the Singapore shares closing of S$0.610 yesterday. Z-Obee, on the other hand, issued new shares in Hong Kong that have surged from their offer price of HK$1.80 to HK$3.21 at yesterday's closing.
Nevertheless, these frontrunners of the dual-listing trend here - China XLX and Z-Obee - have seen their share prices in Singapore improve by 19.6 per cent and 43.6 per cent respectively since their dual listings.
Hengxin Technology and Swing Media have also expressed their intent for dual listings, while Time Watch Investments is said to be exploring this option. Oceanus Group, meanwhile, has chosen the less travelled route of issuing Taiwan Depository Receipts.
</TD></TR></TBODY></TABLE>
